MedTrace Logo

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

NCT00483457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2012-09-03

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue and blood in the laboratory from patients with cancer receiving epidermal growth factor receptor (EGFR) inhibitors may help doctors understand the effects of EGFR inhibitor therapy in the skin.

PURPOSE: This laboratory study is looking at the effects of EGFR inhibitors in the skin of cancer patients.

Conditions

Interventions

DRUG

enzyme inhibitor therapy

enzyme inhibitor therapy

GENETIC

protein expression analysis

protein expression analysis

OTHER

immunohistochemistry staining method

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

laboratory biomarker analysis

PROCEDURE

biopsy

biopsy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt-Ingram Cancer Center

    lead OTHER

Principal Investigators

  • Laura Goff, MD · Vanderbilt-Ingram Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-02-28
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00483457 on ClinicalTrials.gov